Welcome to June’s special edition of Eye on A.I. It’s well known that dogs have superpowers when it comes to smell. A dog can easily sniff out the equivalent of a teaspoon of sugar dissolved in two Olympic swimming pools—about one part in 1 billion. In fact, some dogs are known to be able to detect odors at concentrations as small as one part per trillion. This is a sensitivity hundreds of thousands of times greater than humans. It is the reason that dogs have been trained to detect everything from drugs to cancer. But this training is difficult, time-consuming and expensive, and each animal can usually only be trained to find one set of target scents. Meanwhile, our best electronic means of detecting volatile organic compounds in the air—or on surfaces—are Gas Chromatography/Mass Spectrometry (GC/MS) machines that can cost more than $100,000 and take at least 20 minutes to analyze a sample. Now a startup called Canaery thinks it can read the neurons firing in a dog’s olfactory bulb in real-time and, with the help of machine learning, turn the animal into a detection device able to suss out a vast range of molecules, all without the animal having to be specially trained. “This does for scent what machine vision did for sight,” says Gabriel Lavella, Canaery’s founder and chief executive officer. Canaery, which has a lab in Florida, is developing a small electrode array—Lavella says it is as thin as tissue paper and only a quarter the size of a postage stamp—that would be inserted into the dog’s nose and sit on top of the olfactory bulb. When neurons in the bulb fire, the array would pick up the signal and transmit that firing data wirelessly to a computer that can be attached to the dog’s harness or collar, where the signals are processed. The company is trying to train A.I. software to recognize the firing patterns associated with particular scents. In terms of a machine learning challenge, Lavella says that the neuron firing patterns associated with scents are actually far easier for software to pick out than many tasks involving computer vision, such as object recognition. In some cases, for instance in learning to detect certain cancers, researchers don’t even need to know what the exact compound is that the dog is smelling. The software just has to find the right neuron firing pattern associated with a particular kind of cancer, Lavella says. It can then use the pattern itself as a biomarker of the disease.

The company has just raised $4 million in seed capital in a funding round led by Breakout Ventures and including participation from Dolby Family Ventures, KdT Ventures, and SOSV. “For years we have looked at approaches to digitize scent and have never found a solution as elegant and scalable as Canaery’s technology,” Lindy Fishburne, Breakout Ventures managing partner and a Canaery board member, said in a statement.

So far, Canaery has been using rats—which also have a keen sense of smell—not dogs, for its research. Lavella says the company plans to begin field trials of its technology using rats by the fourth quarter of this year. He says it will take 18 months to two years to have a commercial product involving dogs available. He says the company’s first customers will likely be agencies that do port and border security. And he says there are huge markets for the detection of pests—from cotton weevils and bed bugs—as well as plant and animal diseases that can devastate agriculture. Medical uses of the technology, such as detecting cancer, will come later, he says, as the process to get the method approved by the FDA requires clinical trials. Lavella says that one of the big advantages of using this kind of neuron-computer interface over simply using a trained dog is that the same animal can then be used to cover many more scents. Another advantage is that the device can determine concentrations of a scent, not merely whether it is present. He says that drug smugglers have discovered that a good way to get drugs past dogs is to sprinkle a tiny bit of the contraband everywhere in a container, for example. This way the dog alerts on everything and the customs agents can’t tell where exactly the drugs are hidden. Canaery’s device won’t be thrown off by such tactics, Lavella says. It will allow those monitoring it to tell when concentrations of a scent are rising or dissipating and help them locate a hidden stash. Thanks to A.I., we may soon know what a dog’s nose knows.

Jeremy Kahn @jeremyakahn jeremy.kahn@fortune.com Update, July 1: This story has been updated to reflect the location of Canaery’s new lab in Florida and also to clarify that in future versions of its device, data from the olfactory implant will be transmitted wirelessly to the signal processing computer.

Our mission to make business better is fueled by readers like you. To enjoy unlimited access to our journalism, subscribe today.

© 2022 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell My Personal Information | Ad Choices  FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice. S&P Index data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. Terms & Conditions. Powered and implemented by Interactive Data Managed Solutions.